+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pharmaceuticals Global Group of Eight (G8) Industry Guide - Market Summary, Competitive Analysis and Forecast to 2025

  • ID: 5448551
  • Report
  • August 2021
  • Region: Global
  • 233 Pages
  • MarketLine
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • Apotex, Inc.
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • Daiichi Sankyo Co Ltd
  • GlaxoSmithKline Plc
  • Les Laboratoires Servier
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The G8 Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights


  • The G8 countries contributed $681.2 billion in 2020 to the global pharmaceuticals industry, with a compound annual growth rate (CAGR) of 4.7% between 2016 and 2020. The G8 countries are expected to reach a value of $788.1 billion in 2025, with a CAGR of 3% over the 2020-25 period.
  • Among the G8 nations, the US is the leading country in the pharmaceuticals industry, with market revenues of $387.0 billion in 2020. This was followed by Japan and Germany, with a value of $87.0 and $71.3 billion, respectively.
  • The US is expected to lead the pharmaceuticals industry in the G8 nations with a value of $441.0 billion in 2016, followed by Japan and Germany with expected values of $100.9 and $98.5 billion, respectively.

Scope


  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the G8 pharmaceuticals market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the G8 pharmaceuticals market
  • Leading company profiles reveal details of key pharmaceuticals market players’ G8 operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the G8 pharmaceuticals market with five year forecasts
  • Compares data from the US, Canada, Germany, France, UK, Italy, Russia and Japan, alongside individual chapters on each country

Reasons to Buy


  • What was the size of the G8 pharmaceuticals market by value in 2020?
  • What will be the size of the G8 pharmaceuticals market in 2025?
  • What factors are affecting the strength of competition in the G8 pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in the G8 pharmaceuticals market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Apotex, Inc.
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • Daiichi Sankyo Co Ltd
  • GlaxoSmithKline Plc
  • Les Laboratoires Servier

1 Introduction
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions
2 Group of Eight (G8) Pharmaceuticals
2.1. Industry Outlook
3 Pharmaceuticals in Canada
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
3.6. Macroeconomic Indicators
4 Pharmaceuticals in France
4.1. Market Overview
4.2. Market Data
4.3. Market Segmentation
4.4. Market outlook
4.5. Five forces analysis
4.6. Macroeconomic Indicators
5 Pharmaceuticals in Germany
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
5.6. Macroeconomic Indicators
6 Pharmaceuticals in Italy
6.1. Market Overview
6.2. Market Data
6.3. Market Segmentation
6.4. Market outlook
6.5. Five forces analysis
6.6. Macroeconomic Indicators
7 Pharmaceuticals in Japan
7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis
7.6. Macroeconomic Indicators
8 Pharmaceuticals in Russia
8.1. Market Overview
8.2. Market Data
8.3. Market Segmentation
8.4. Market outlook
8.5. Five forces analysis
8.6. Macroeconomic Indicators
9 Pharmaceuticals in The United Kingdom
9.1. Market Overview
9.2. Market Data
9.3. Market Segmentation
9.4. Market outlook
9.5. Five forces analysis
9.6. Macroeconomic Indicators
10 Pharmaceuticals in The United States
10.1. Market Overview
10.2. Market Data
10.3. Market Segmentation
10.4. Market outlook
10.5. Five forces analysis
10.6. Macroeconomic Indicators
11 Company Profiles
11.1. Johnson & Johnson
11.2. Pfizer Inc.
11.3. Apotex, Inc.
11.4. Merck & Co., Inc.
11.5. Sanofi SA
11.6. Laboratoires Pierre Fabre SA
11.7. F. Hoffmann-La Roche Ltd
11.8. Boehringer Ingelheim GmbH
11.9. A Menarini Industrie Farmaceutiche Riunite Srl
11.10. Chiesi Farmaceutici SpA
11.11. Recordati S.p.A.
11.12. Daiichi Sankyo Co Ltd
11.13. Astellas Pharma Inc.
11.14. Mitsubishi Tanabe Pharma Corporation
11.15. Takeda Pharmaceutical Company Limited
11.16. Bayer AG
11.17. Les Laboratoires Servier
11.18. Novartis AG
11.19. GlaxoSmithKline Plc
11.20. AstraZeneca PLC
12 Appendix
12.1. Methodology
12.2. About the Publisher
List of Tables
Table 1: G8 pharmaceuticals industry, revenue($bn), 2016-25
Table 2: G8 pharmaceuticals industry, revenue by country ($bn), 2016-20
Table 3: G8 pharmaceuticals industry forecast, revenue by country ($bn), 2020-25
Table 4: Canada pharmaceuticals market value: $ billion, 2016-20
Table 5: Canada pharmaceuticals market geography segmentation: $ billion, 2020
Table 6: Canada pharmaceuticals market share: % share, by value, 2020
Table 7: Canada pharmaceuticals market value forecast: $ billion, 2020-25
Table 8: Canada size of population (million), 2016-20
Table 9: Canada GDP (constant 2005 prices, $ billion), 2016-20
Table 10: Canada GDP (current prices, $ billion), 2016-20
Table 11: Canada inflation, 2016-20
Table 12: Canada consumer price index (absolute), 2016-20
Table 13: Canada exchange rate, 2016-20
Table 14: France pharmaceuticals market value: $ billion, 2016-20
Table 15: France pharmaceuticals market geography segmentation: $ billion, 2020
Table 16: France pharmaceuticals market share: % share, by value, 2020
Table 17: France pharmaceuticals market value forecast: $ billion, 2020-25
Table 18: France size of population (million), 2016-20
Table 19: France GDP (constant 2005 prices, $ billion), 2016-20
Table 20: France GDP (current prices, $ billion), 2016-20
Table 21: France inflation, 2016-20
Table 22: France consumer price index (absolute), 2016-20
Table 23: France exchange rate, 2016-20
Table 24: Germany pharmaceuticals market value: $ billion, 2016-20
Table 25: Germany pharmaceuticals market geography segmentation: $ billion, 2020
Table 26: Germany pharmaceuticals market share: % share, by value, 2020
Table 27: Germany pharmaceuticals market value forecast: $ billion, 2020-25
Table 28: Germany size of population (million), 2016-20
Table 29: Germany GDP (constant 2005 prices, $ billion), 2016-20
Table 30: Germany GDP (current prices, $ billion), 2016-20
Table 31: Germany inflation, 2016-20
Table 32: Germany consumer price index (absolute), 2016-20
Table 33: Germany exchange rate, 2016-20
Table 34: Italy pharmaceuticals market value: $ billion, 2016-20
Table 35: Italy pharmaceuticals market geography segmentation: $ billion, 2020
Table 36: Italy pharmaceuticals market share: % share, by value, 2020
Table 37: Italy pharmaceuticals market value forecast: $ billion, 2020-25
Table 38: Italy size of population (million), 2016-20
Table 39: Italy GDP (constant 2005 prices, $ billion), 2016-20
Table 40: Italy GDP (current prices, $ billion), 2016-20
Table 41: Italy inflation, 2016-20
Table 42: Italy consumer price index (absolute), 2016-20
Table 43: Italy exchange rate, 2016-20
Table 44: Japan pharmaceuticals market value: $ billion, 2016-20
Table 45: Japan pharmaceuticals market geography segmentation: $ billion, 2020
Table 46: Japan pharmaceuticals market share: % share, by value, 2020
Table 47: Japan pharmaceuticals market value forecast: $ billion, 2020-25
Table 48: Japan size of population (million), 2016-20
Table 49: Japan GDP (constant 2005 prices, $ billion), 2016-20
Table 50: Japan GDP (current prices, $ billion), 2016-20
Table 51: Japan inflation, 2016-20
Table 52: Japan consumer price index (absolute), 2016-20
Table 53: Japan exchange rate, 2016-20
Table 54: Russia pharmaceuticals market value: $ billion, 2016-20
Table 55: Russia pharmaceuticals market geography segmentation: $ billion, 2020
Table 56: Russia pharmaceuticals market share: % share, by value, 2020
Table 57: Russia pharmaceuticals market value forecast: $ billion, 2020-25
Table 58: Russia size of population (million), 2016-20
Table 59: Russia GDP (constant 2005 prices, $ billion), 2016-20
Table 60: Russia GDP (current prices, $ billion), 2016-20
Table 61: Russia inflation, 2016-20
Table 62: Russia consumer price index (absolute), 2016-20
Table 63: Russia exchange rate, 2016-20
Table 64: United Kingdom pharmaceuticals market value: $ billion, 2016-20
Table 65: United Kingdom pharmaceuticals market geography segmentation: $ billion, 2020
Table 66: United Kingdom pharmaceuticals market share: % share, by value, 2020
Table 67: United Kingdom pharmaceuticals market value forecast: $ billion, 2020-25
Table 68: United Kingdom size of population (million), 2016-20
Table 69: United Kingdom GDP (constant 2005 prices, $ billion), 2016-20
Table 70: United Kingdom GDP (current prices, $ billion), 2016-20
Table 71: United Kingdom inflation, 2016-20
Table 72: United Kingdom consumer price index (absolute), 2016-20
List of Figures
Figure 1: G8 pharmaceuticals industry, revenue($bn), 2016-25
Figure 2: G8 Pharmaceuticals industry, revenue by country (%), 2020
Figure 3: G8 pharmaceuticals industry, revenue by country ($bn), 2016-20
Figure 4: G8 pharmaceuticals industry forecast, revenue by country ($bn), 2020-25
Figure 5: Canada pharmaceuticals market value: $ billion, 2016-20
Figure 6: Canada pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 7: Canada pharmaceuticals market share: % share, by value, 2020
Figure 8: Canada pharmaceuticals market value forecast: $ billion, 2020-25
Figure 9: Forces driving competition in the pharmaceuticals market in Canada, 2020
Figure 10: Drivers of buyer power in the pharmaceuticals market in Canada, 2020
Figure 11: Drivers of supplier power in the pharmaceuticals market in Canada, 2020
Figure 12: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Canada, 2020
Figure 13: Factors influencing the threat of substitutes in the pharmaceuticals market in Canada, 2020
Figure 14: Drivers of degree of rivalry in the pharmaceuticals market in Canada, 2020
Figure 15: France pharmaceuticals market value: $ billion, 2016-20
Figure 16: France pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 17: France pharmaceuticals market share: % share, by value, 2020
Figure 18: France pharmaceuticals market value forecast: $ billion, 2020-25
Figure 19: Forces driving competition in the pharmaceuticals market in France, 2020
Figure 20: Drivers of buyer power in the pharmaceuticals market in France, 2020
Figure 21: Drivers of supplier power in the pharmaceuticals market in France, 2020
Figure 22: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2020
Figure 23: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2020
Figure 24: Drivers of degree of rivalry in the pharmaceuticals market in France, 2020
Figure 25: Germany pharmaceuticals market value: $ billion, 2016-20
Figure 26: Germany pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 27: Germany pharmaceuticals market share: % share, by value, 2020
Figure 28: Germany pharmaceuticals market value forecast: $ billion, 2020-25
Figure 29: Forces driving competition in the pharmaceuticals market in Germany, 2020
Figure 30: Drivers of buyer power in the pharmaceuticals market in Germany, 2020
Figure 31: Drivers of supplier power in the pharmaceuticals market in Germany, 2020
Figure 32: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2020
Figure 33: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2020
Figure 34: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2020
Figure 35: Italy pharmaceuticals market value: $ billion, 2016-20
Figure 36: Italy pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 37: Italy pharmaceuticals market share: % share, by value, 2020
Figure 38: Italy pharmaceuticals market value forecast: $ billion, 2020-25
Figure 39: Forces driving competition in the pharmaceuticals market in Italy, 2020
Figure 40: Drivers of buyer power in the pharmaceuticals market in Italy, 2020
Figure 41: Drivers of supplier power in the pharmaceuticals market in Italy, 2020
Figure 42: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Italy, 2020
Figure 43: Factors influencing the threat of substitutes in the pharmaceuticals market in Italy, 2020
Figure 44: Drivers of degree of rivalry in the pharmaceuticals market in Italy, 2020
Figure 45: Japan pharmaceuticals market value: $ billion, 2016-20
Figure 46: Japan pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 47: Japan pharmaceuticals market share: % share, by value, 2020
Figure 48: Japan pharmaceuticals market value forecast: $ billion, 2020-25
Figure 49: Forces driving competition in the pharmaceuticals market in Japan, 2020
Figure 50: Drivers of buyer power in the pharmaceuticals market in Japan, 2020
Figure 51: Drivers of supplier power in the pharmaceuticals market in Japan, 2020
Figure 52: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Japan, 2020
Figure 53: Factors influencing the threat of substitutes in the pharmaceuticals market in Japan, 2020
Figure 54: Drivers of degree of rivalry in the pharmaceuticals market in Japan, 2020
Figure 55: Russia pharmaceuticals market value: $ billion, 2016-20
Figure 56: Russia pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 57: Russia pharmaceuticals market share: % share, by value, 2020
Figure 58: Russia pharmaceuticals market value forecast: $ billion, 2020-25
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Johnson & Johnson
  • Pfizer Inc.
  • Apotex, Inc.
  • Merck & Co., Inc.
  • Sanofi SA
  • Laboratoires Pierre Fabre SA
  • F. Hoffmann-La Roche Ltd
  • Boehringer Ingelheim GmbH
  • A Menarini Industrie Farmaceutiche Riunite Srl
  • Chiesi Farmaceutici SpA
  • Recordati S.p.A.
  • Daiichi Sankyo Co Ltd
  • Astellas Pharma Inc.
  • Mitsubishi Tanabe Pharma Corporation
  • Takeda Pharmaceutical Company Limited
  • Bayer AG
  • Les Laboratoires Servier
  • Novartis AG
  • GlaxoSmithKline Plc
  • AstraZeneca PLC
Note: Product cover images may vary from those shown